drugset
drugset / Trial / NCT05215132

Investigational MRI Clinical Software and Hardware

NCT05215132 ↗

Phase 4 Recruiting 2000 enrolled Northwestern University
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

Patients and healthy volunteers will be scanned in order to test new sequences.

Timeline

Start
2019-12-19
Primary completion
2028-01-31
Completion
2028-01-31

Drugs

EvaluationDrugModalityDoseRoute
Background Gadobutrol Diagnostic / imaging agent 2 ml —

Indications

No indication recorded.